Cargando…
Cutaneous leukocytoclastic vasculitis due to anti-tuberculosis medications, rifampin and pyrazinamide
Anti-tuberculosis drugs frequently result in cutaneous adverse reactions, including pruritus, maculopapular exanthems, and urticaria. However, anti-tuberculosis drug-associated cutaneous leukocytoclastic vasculitis (CLV) has been rarely reported. We describe a case of CLV induced by rifampin and pyr...
Autores principales: | Kim, Joo-Hee, Moon, Jun-Il, Kim, Jeong Eun, Choi, Gil-Soon, Park, Hae-Sim, Ye, Young-Min, Yim, Hyunee |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
The Korean Academy of Asthma, Allergy and Clinical Immunology; The Korean Academy of Pediatric Allergy and Respiratory Disease
2010
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2831607/ https://www.ncbi.nlm.nih.gov/pubmed/20224679 http://dx.doi.org/10.4168/aair.2010.2.1.55 |
Ejemplares similares
-
Gastroenterology Cases of Cutaneous Leukocytoclastic Vasculitis
por: Karatoprak, Cumali, et al.
Publicado: (2013) -
Cutaneous Leukocytoclastic Vasculitis Associated with Erlotinib
por: Sawada, Takahiro, et al.
Publicado: (2016) -
The molecular basis of resistance to isoniazid, rifampin, and pyrazinamide in Mycobacterium tuberculosis
por: Somoskovi, Akos, et al.
Publicado: (2001) -
Cutaneous Leukocytoclastic Vasculitis with Gastrointestinal Involvement after Anti-Tuberculosis Treatment
por: Shim, Sangwoo, et al.
Publicado: (2017) -
Cutaneous leukocytoclastic vasculitis in the presence of
methimazole therapy
por: Ribeiro, Carla de Oliveira, et al.
Publicado: (2013)